GLP-1 is a target for treatment of diabetes because of the primary peripheral functions of inducing insulin secretion from pancreatic β cells, gut emptying and inhibiting glucagon secretion which results in lower blood glucose levels (20). The gene discussed is GCG; the disease is diabetes mellitus.